Takeshi Ioroi

428 total citations
25 papers, 311 citations indexed

About

Takeshi Ioroi is a scholar working on Oncology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Takeshi Ioroi has authored 25 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pharmacology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Takeshi Ioroi's work include Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Chemotherapy-related skin toxicity (4 papers). Takeshi Ioroi is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Chemotherapy-related skin toxicity (4 papers). Takeshi Ioroi collaborates with scholars based in Japan, Greece and United States. Takeshi Ioroi's co-authors include Hiroshi Iwao, Yumei Zhan, Eiichiro Yamamoto, Tomoko Tanaka, Hideki Wanibuchi, Yasuhiro Izumiya, Shokei Kim‐Mitsuyama, Yasukatsu Izumi, Midori Hirai and Kazuhiro Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Stroke.

In The Last Decade

Takeshi Ioroi

23 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Ioroi Japan 9 108 57 51 49 46 25 311
Jianfang Liu China 11 31 0.3× 127 2.2× 43 0.8× 55 1.1× 51 1.1× 17 499
Julia Y.H. Liu Hong Kong 8 24 0.2× 113 2.0× 62 1.2× 23 0.5× 93 2.0× 21 357
Terézia B. Andrási Germany 8 55 0.5× 52 0.9× 22 0.4× 55 1.1× 36 0.8× 25 324
Wolfgang Uhl Germany 9 27 0.3× 93 1.6× 37 0.7× 37 0.8× 81 1.8× 17 340
Hong Bian China 12 53 0.5× 157 2.8× 25 0.5× 36 0.7× 72 1.6× 27 488
Chung‐Hsiang Liu Taiwan 12 71 0.7× 92 1.6× 8 0.2× 18 0.4× 26 0.6× 20 473
Huan Xue China 9 88 0.8× 184 3.2× 28 0.5× 32 0.7× 64 1.4× 18 460
S. Lu China 14 37 0.3× 113 2.0× 56 1.1× 6 0.1× 61 1.3× 39 426
Wolfram Nothaft United States 12 54 0.5× 188 3.3× 25 0.5× 74 1.5× 294 6.4× 13 571

Countries citing papers authored by Takeshi Ioroi

Since Specialization
Citations

This map shows the geographic impact of Takeshi Ioroi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Ioroi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Ioroi more than expected).

Fields of papers citing papers by Takeshi Ioroi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Ioroi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Ioroi. The network helps show where Takeshi Ioroi may publish in the future.

Co-authorship network of co-authors of Takeshi Ioroi

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Ioroi. A scholar is included among the top collaborators of Takeshi Ioroi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Ioroi. Takeshi Ioroi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakei, Yasumasa, Takeshi Ioroi, Masaki Kobayashi, et al.. (2025). Efficacy of Ibuprofen Gargle for Oral Lichen Planus: A Single-Center, Placebo-Controlled, Double-Blind, Randomized Crossover Study Trial. Cureus. 17(8). e91242–e91242.
3.
Kakei, Yasumasa, Takeshi Ioroi, Keiko Miyakoda, et al.. (2024). Assessment of Patient Characteristics Influencing the Analgesic Effects of Ibuprofen Gargle After Mandibular Third Molar Extractions. Cureus. 16(4). e57516–e57516. 2 indexed citations
4.
Ioroi, Takeshi, Yasumasa Kakei, Junya Yamashita, et al.. (2023). Efficacy and Long-Term Safety of Ibuprofen Gargle for Oral Lichen Planus: A Study Protocol of Randomized Crossover and Long-Term Extension Trials. Methods and Protocols. 6(1). 7–7. 1 indexed citations
5.
Ioroi, Takeshi, Yasumasa Kakei, T. Shirai, et al.. (2023). Efficacy and safety of ibuprofen gargle for postoperative pain after mandibular third molar extraction: A phase II, placebo‐controlled, double‐blind, randomized crossover trial. Clinical and Experimental Dental Research. 9(6). 1058–1068. 4 indexed citations
7.
Ioroi, Takeshi, Naomi Kiyota, Yoshinori Imamura, et al.. (2020). Ibuprofen gargle for chemo- or Chemoradiotherapy-induced Oral Mucositis: a feasibility study. Journal of Pharmaceutical Health Care and Sciences. 6(1). 12–12. 11 indexed citations
9.
Ioroi, Takeshi, Junya Furukawa, Manabu Kume, et al.. (2017). Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy. Supportive Care in Cancer. 26(5). 1419–1423. 5 indexed citations
10.
Yamamoto, Kazuhiro, Takeshi Ioroi, Kazuaki Shinomiya, et al.. (2016). STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population. Medical Oncology. 33(3). 24–24. 8 indexed citations
11.
Kimura, Takeshi, Atsushi Uda, Yuko Akazawa, et al.. (2016). Pharmaceutical Intervention to Manage Polypharmacy in Elderly Patients based on STOPP Criteria. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42(2). 78–86. 5 indexed citations
12.
Ioroi, Takeshi, et al.. (2015). Data analysis methods for assessing palliative care interventions in one-group pre–post studies. SHILAP Revista de lepidopterología. 3. 2102693313–2102693313. 1 indexed citations
14.
Yamamoto, Kazuhiro, Takeshi Ioroi, Kazuaki Shinomiya, et al.. (2015). Association of single nucleotide polymorphisms (SNP) in STAT3 gene with hand-foot skin reaction in metastatic renal cell carcinoma patients treated with multi-kinase inhibitor.. Journal of Clinical Oncology. 33(15_suppl). e15622–e15622. 1 indexed citations
15.
Ioroi, Takeshi, Kohshi Nishiguchi, Motohiro Yamamori, et al.. (2014). Serum Lactate Dehydrogenase Levels as a Predictive Marker of Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer. International Journal of Medical Sciences. 11(6). 641–645. 9 indexed citations
16.
Sakashita, Akihiro, Yuki Ishibashi, Takeshi Ioroi, et al.. (2012). Evaluation of QOL in cancer patients under intervention by a palliative care team. Palliative Care Research. 7(2). 368–373. 2 indexed citations
17.
Ioroi, Takeshi, M. Fujii, Kohshi Nishiguchi, et al.. (2011). Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer. International Journal of Medical Sciences. 8(3). 210–215. 23 indexed citations
18.
Ioroi, Takeshi, et al.. (2008). Multicenter Trial on Hypersensitivity Reactions following Treatment with FOLFOX Regimens. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 34(10). 919–926. 3 indexed citations
19.
Nakamura, Tsutomu, Takeshi Ioroi, Toshiyuki Sakaeda, et al.. (2006). Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients. International Journal of Medical Sciences. 3(3). 92–96. 8 indexed citations
20.
Ioroi, Takeshi, Motohiro Yamamori, Keiko Yagi, et al.. (2003). Dominant Negative c-Jun Inhibits Platelet-Derived Growth Factor-Directed Migration by Vascular Smooth Muscle Cells. Journal of Pharmacological Sciences. 91(2). 145–148. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026